As a result of pressure from the Trump administration to move forward more quickly for a remedy, the Food and Drug Administration has developed an emergency authorization strategy to treat Covid-19 patients with convalescent plasma. The convalescent plasma, which is made using blood from people who have recovered from coronavirus infections, has been used to …